Recce breathes better on positive lung infection drug pilot test results
Recce Pharmaceuticals Ltd has revealed positive results from its pilot test on synthetic drug Recce 327, which aims to treat lung infections.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
BSX | Media | 10/05/24 | 2.6K | 662K | |||
|
|||||||
BSX | Ann: Extension of Closing Date - Retail Entitlement Offer | 10/05/24 | 53 | 15K | |||
|
|||||||
BSX | Ann: Application for quotation of securities - BSX | 06/05/24 | 1 | 509 | |||
|
|||||||
BSX | Ann: Cleansing Notice | 06/05/24 | 0 | 210 | |||
|
|||||||
BSX | Ann: Quarterly Activities/Appendix 5B Cash Flow Report | 25/04/24 | 4 | 1.3K | |||
|
|||||||
BSX | Ann: Change in substantial holding | 23/04/24 | 16 | 4.9K | |||
|
|||||||
BSX | Ann: Funds received from partial sale of Codrus Shares | 17/04/24 | 9 | 2.5K | |||
|
|||||||
BSX | Company presenting TUESDAY at Future Facing Commodities Conference - FREE livestream available | 25/03/24 | 0 | 305 | |||
|
See All Discussions
Timeline
|
|||||
|
|||||
|
|||||
|
|||||
|
|||||
|
|||||
View More |